Enveda
Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.
$311MSeries E
ParticipantL
Lightspeed
Activity from announced rounds
Activity in this selectionOct 15, 2026 · Biotech · Sep 16, 2026
Lightspeed Venture Partners invests from seed through growth in enterprise, consumer, fintech and healthcare companies, with a global investment platform.
Its sector teams approach different company-building problems: enterprise adoption, changes in consumer behaviour, financial infrastructure and unmet clinical needs. The partnership includes former founders and operators with domain experience, so the relevant team depends on the business being built rather than a single firm-wide industry thesis.
Lightspeed’s healthcare practice focuses on technologies that can improve patient outcomes. In fintech, its stated interests span the financial technology stack, including blockchain, rather than being limited to consumer banking applications.
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $311M 1 disclosed · full round size, not this investor’s share